Right on schedule with these ALS results. That suggests we'll close green and break $4.
Look it up. Been the plan all along. Build a great product (check), get approval (check), secure adoption (in process), sell the company for a nice profit. We're on track. Acquisition price is somewhere north of $40.
I bought more shares. Seems cheap.
Is $32 your target as well, or do you think they'll push it below $30? A safe range would be around $26 or so.
Hoping news comes this week. It's been a couple since this was mentioned at the congressional hearing. A multi-million dollar deal with HHS would send this stock into the $70's.
Why would Roche care about a Phase 1 product? Something else in the works here. Roche has other motives at play. I think this goes back to the comments made at the congressional hearing about another large pharmaceutical that will be helping NewLink manufacturer Ebola vaccine.
I believe GSK said this weekend they are bowing out. I saw an earlier post about that, I'm looking for the article now. If someone has a link please post it.
Video is available on CSPAN for other investors to review.
Absolutely not. My point was to only illustrate how absurdly low the current valuation at $20 is.
At the congressional hearing last week, it the HHS doctor let it slip that NewLink was working with "A Large American Company" (see CSPAN video). A big pharmaceutical like JnJ or Pfizer could easily ramp and help produce that many does. I'd expect an announcement this week.
Assume 20 million people will need a vaccine (includes all first responders and United states military). Now assume each vaccine shot costs $100 (that's conservative). That's $2 Billion dollars of revenue. As of Friday NLNK's market cap was only $819 Million. To get to a market cap of $2 Billion, the stock needs to rise 2.4x. That puts a valuation of $71/share on NLNK.
Have a great weekend.
IBIO will help make ZMapp which is a "cure" once you have Ebola. NLNK is making a vaccine which would be used to prevent infection. They would likely vaccinate the military and all healthcare workers with NewLink's vaccine, and treat patients with Caliber's drug.
I own both stocks. You should too. Buy and hold my friend. Government contracts coming.
It's NewLink. Start the video at 1:30:10. The entire conversation is about NewLink Genetics in Iowa.
c-span . org /video/?321976-1/hearing-us-response-ebola-outbreak
In reference to NewLink's Vaccine ramp-up. HHS Dr Robinson said:
1:31:40 "Working with them to expand their production with other companies including A VERY LARGE COPANY here in the United States"
Um, was that a slip? Are we about to get a collaboration announcement with NewLink and a major Pharmaceutical? Perhaps Merck, Pfizier, or JnJ?
Last year alone they booked $91m in revenue. Add in the current Ebola crisis and it would seem that this year, they revenue will exceed their market cap. From a valuation standpoint a company like this would generally command a $250-300m market cap. That's 2.5x-3x the current stock price ($50-$60/share)